Defining Distinct Subtypes of NECs to Predict Therapeutic Vulnerabilities
Carl Gay, MD, PhD
Funded Research Projects
Molecular Heterogeneity in Pancreatic Neuroendocrine Tumor (moYpan)
Jerome Cros, PhD
A Human Pluripotent Stem Cell-based Model for Lung Carcinoid
Huanhuan Chen, PhD
Investigating PanNet Tumorigenesis with Single Cell Genomics
Chang Chan, PhD
PRESCIENT – PET ResponSe CrItEria for Neuroendocrine Tumors
Lisa Bodei, MD, PhD
PANNET Modeling, Mechanisms, and Experimental Treatment
James Bibb, PhD
NET-SMART Therapy: A Targeted Prodrug Strategy (II)
Justin Annes, MD, PhD
Molecular Influences of Racial Disparities in Pancreatic Neuroendocrine Tumors
J. Bart Rose, III, MD, MAS, FACS
Targeted alpha therapy of NETs using somatostatin-based radiopharmaceuticals with improved tumor-to-kidney ratio, the theranostic approach.
Prof. Dr. Apr. Frederik Cleeren
Mesenteric fibrosis in small intestinal neuroendocrine tumors: pathogenesis
Martyn Caplin, DM, FRCP